Last Friday during the after-market session, there was a noticeable increase in the shares of Jaguar Health, Inc. (NASDAQ: JAGX) following the announcement of a
During pre-market trading on Tuesday, Jaguar Health Inc. (JAGX) climbed 2.55% to $1.61. The Jaguar Health stock finished the last trading session down -4.85% at
Jaguar Health has had swift growth in 2020 as the demand for its Mytesi continues to rise. The pharmaceutical firm has kicked off the new
Jaguar Health has decided to develop and commercialize Crofelemer for the treatment of COVID-19 recovery patients suffering from long-term diarrhea. The study is planned to
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.